Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung Study
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Achieve Life Sciences
People's Hospital of Xinjiang Uygur Autonomous Region
Institut Claudius Regaud
National Institutes of Health Clinical Center (CC)
Vastra Gotaland Region
AstraZeneca
Bristol-Myers Squibb
Ohio State University Comprehensive Cancer Center
Travera Inc
The Methodist Hospital Research Institute
Montefiore Medical Center
Sandoz
IO Biotech
Novartis
Amgen
Gustave Roussy, Cancer Campus, Grand Paris
AstraZeneca
M.D. Anderson Cancer Center
Affiliated Hospital of Nantong University
Brown University
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
Novartis
Roswell Park Cancer Institute
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Pfizer
Daiichi Sankyo
Shanxi Province Cancer Hospital
The Christie NHS Foundation Trust
Faculty of Medicine of Tunis
NovoCure Ltd.
Dragonfly Therapeutics
Dragonfly Therapeutics
Dragonfly Therapeutics
Merck Sharp & Dohme LLC
Duke University
Roswell Park Cancer Institute
Seagen Inc.
Merck Sharp & Dohme LLC
Centre Oscar Lambret
Centre Oscar Lambret
Ono Pharmaceutical Co. Ltd
University of Kentucky
Pfizer
AstraZeneca
Emory University
NeoImmuneTech
Institut Bergonié